GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Stella Pharma Corp (TSE:4888) » Definitions » EPS (Diluted)

Stella Pharma (TSE:4888) EPS (Diluted) : 円-25.31 (TTM As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Stella Pharma EPS (Diluted)?

Stella Pharma's Earnings per Share (Diluted) for the three months ended in Dec. 2023 was 円-5.24. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was 円-25.31.

Stella Pharma's EPS (Basic) for the three months ended in Dec. 2023 was 円-5.24. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 was 円-25.31.

Stella Pharma's EPS without NRI for the three months ended in Dec. 2023 was 円-5.24. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 was 円-25.29.

During the past 3 years, the average EPS without NRIGrowth Rate was 8.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 5 years, Stella Pharma's highest 3-Year average EPS without NRI Growth Rate was 8.30% per year. The lowest was 4.30% per year. And the median was 6.30% per year.


Stella Pharma EPS (Diluted) Historical Data

The historical data trend for Stella Pharma's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stella Pharma EPS (Diluted) Chart

Stella Pharma Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23
EPS (Diluted)
-31.20 -48.11 -32.90 -27.34 -26.97

Stella Pharma Quarterly Data
Mar19 Mar20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.85 -10.12 -5.44 -4.51 -5.24

Competitive Comparison of Stella Pharma's EPS (Diluted)

For the Biotechnology subindustry, Stella Pharma's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Stella Pharma's PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Stella Pharma's PE Ratio distribution charts can be found below:

* The bar in red indicates where Stella Pharma's PE Ratio falls into.



Stella Pharma EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Stella Pharma's Diluted EPS for the fiscal year that ended in Mar. 2023 is calculated as

Diluted EPS (A: Mar. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-778.824-0)/28.877
=-26.97

Stella Pharma's Diluted EPS for the quarter that ended in Dec. 2023 is calculated as

Diluted EPS (Q: Dec. 2023 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-163.705-0)/31.227
=-5.24

EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-25.31

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Stella Pharma  (TSE:4888) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Stella Pharma EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Stella Pharma's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Stella Pharma (TSE:4888) Business Description

Traded in Other Exchanges
N/A
Address
3-2-7 Korai-bashi, Chuo-ku, Osaka Prefecture, Osaka, JPN, 541-0043
Stella Pharma Corp is a therapeutic drug research and development company. It is focused on the development of boron compounds, particularly used in boron neutron capture therapy (BNCT). The BNCT is a form of cancer radiation therapy for destroying cancer cells.

Stella Pharma (TSE:4888) Headlines

No Headlines